Menu

Support earlier breast cancer detection.

A home based screening tool that helps activate patients, increase screening adherence, and extend your care beyond the clinic.

Partner with Auria

Auria in your practice — a home tool delivering health activation.

providers tile physicians

Your patients are busy.
So are you.

Auria helps extend breast health conversations beyond the visit.
By offering an accessible, at home screening option, Auria supports more personalized discussions, encourages appropriate follow up, and helps patients stay engaged in their breast health between appointments.

Personalized Answers

Support clearer screening conversations.

Accessible Screening

Reach patients facing barriers to care.

Focus
providers tile support

How can we support your practice?

Flexible ways to integrate Auria into your care model.
Whether you refer patients to an at home option or offer Auria directly in office, our approach is designed to fit seamlessly into your existing workflow.

Refer patients

Direct patients to Auria for at home testing.

Offer in office

Administer the Auria tear test on site.

Focus

Advancing breast health together. 

2000+

Clinically evaluated samples

91.5%

Detects elevated risk

58%

Balanced clinical performance

“As a family practice physician for 23 years, I have seen the negative impact of a delayed or late stage breast cancer diagnosis. Thankfully, my own breast cancer was diagnosed at an early stage.

I am thankful we have Auria to help ensure we don’t miss an opportunity to increase education and screening for breast health. Auria gives the ability to check breast health from the comfort of home and increase appropriate screening such as mammograms.

Through Auria, education, and screening hopefully more breast cancers can be diagnosed at early stage.”

Dr. Susan Rogerson
Fayetteville, AR
Dr. Susan Rogerson
Introduction to Auria for Health Care Providers
Download the physician brochure to learn more about Auria
Our publications
Tears as the Next Diagnostic Biofluid: A Comparative Study between Ocular Fluid and Blood
Aug 2022
In this study, both the genomic and proteomic profiles of tears and blood are evaluated to determine the similarity and differences between the two biofluids.
Using tears as a non-invasive source for early detection of breast cancer
Apr 2022
In this study, we examined the ocular proteome to identify protein biomarkers with altered expression levels in women diagnosed with breast cancer.

For all bodies, all breasts.

Learn More

For Employers

Let’s empower breast health.

Need assistance?

We’re here to help.